Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03662126
Brief Title: KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment (BOREAS)

First Submitted : September 5, 2018
First Submitted that Met QC Criteria : September 5, 2018
First Posted : September 7, 2018

Last Update Submitted that Met QC Criteria : January 28, 2021
Last Update Posted : February 2, 2021